Ranolazine Loading to Prevent PCI-induced Myocardial Injury
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
It has previously been shown that pretreatment with ranolazine 1,000 mg twice daily for 7
days can significantly reduce procedural myocardial injury in elective percutaneous coronary
intervention (PCI). The investigators tested the hypothesis that twice overnight high-dose
ranolazine loading before PCI can reduce the peri-procedural myocardial ischemic damage
similarly to long-term pre-treatment with standard doses.